The most commonly used therapeutic targets in nephrology are the reduction of injury, the
delay of progression, or renal replacement therapy. Many animal and human studies …

Every year 13.3 million people suffer acute kidney injury (AKI), which is associated with a
high risk of death or development of long-term chronic kidney disease (CKD) in a substantial …

PURPOSE: The potential use of stem cells for acute and chronic renal injury is under
intensive investigation. We summarized the current literature on the potential therapeutic …

Hundreds of clinical trials are currently investigating the potential for mesenchymal stem
cells (MSC) to treat human disease, including kidney disease. There is tremendous …

Chronic renal failure is an important clinical problem with significant socioeconomic impact
worldwide. Despite advances in renal replacement therapies and organ transplantation …

Mesenchymal stem cell (MSC) has been implied to have the therapeutic potential on chronic
kidney disease (CKD). However, the underlying mechanism is still unclear and …

Kidney disease can be either acute kidney injury (AKI) or chronic kidney disease (CKD) and
it can lead to the development of functional organ failure. Mesenchymal stem cells (MSCs) …

Background: Although renal tubular epithelium has a great capacity for repair it has been
suggested that the administration of mesenchymal stem cells may accelerate the recovery …

Importance of the field: Chronic kidney disease (CKD) has become a worldwide public
health problem. Renal transplantation is the treatment of choice for end-stage renal disease …

BACKGROUND: Ischemia and reperfusion injury (I/R) is the major cause of acute renal
failure (ARF) with high mortality rates. Because alternative therapies are needed, we …